![](/img/cover-not-exists.png)
Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial
Bissler, John J, Kingswood, J Christopher, Radzikowska, Elżbieta, Zonnenberg, Bernard A, Frost, Michael, Belousova, Elena, Sauter, Matthias, Nonomura, Norio, Brakemeier, Susanne, de Vries, Petrus J, WVolume:
381
Language:
english
Journal:
The Lancet
DOI:
10.1016/S0140-6736(12)61767-X
Date:
March, 2013
File:
PDF, 286 KB
english, 2013